Welcome!

Microsoft Cloud Authors: Pat Romanski, Liz McMillan, Lori MacVittie, Elizabeth White, Yeshim Deniz

News Feed Item

Implantable Medical Devices Market (Reconstructive Joint Replacement, Spinal Implants, Cardiovascular Implants, Dental Implants, Intraocular Lens And Breast Implants) - U.S. Industry Analysis, Size, Share, Trends, Growth And Forecast, 2012 - 2018

NEW YORK, Feb. 20, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Implantable Medical Devices Market (Reconstructive Joint Replacement, Spinal Implants, Cardiovascular Implants, Dental Implants, Intraocular Lens And Breast Implants) - U.S. Industry Analysis, Size, Share, Trends, Growth And Forecast, 2012 - 2018

http://www.reportlinker.com/p01103868/Implantable-Medical-Devices-Market-Reconstructive-Joint-Replacement-Spinal-Implants-Cardiovascular-Implants-Dental-Implants-Intraocular-Lens-And-Breast-Implants---US-Industry-Analysis-Size-Share-Trends-Growth-And-Forecast-2012---2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Orthopedic

Description

This report covers major aspects of the U.S. implantable medical devices market. It covers the performance of the major types of implantable devices in terms of their revenue, and the market is classified according to the number of procedures performed. The overall implantable medical devices market is classified as orthopedic implants, cardiovascular implants and other (dental, intraocular lens and breast) implants market. The report also provides extensive analysis of the sub-segments of the market considering 2011 as the base year for market size calculations and forecast from 2012 to 2018.

The orthopedic implants market is classified on the basis of types of orthopedic implants and orthopedic implantation procedures. The analysis covers the estimated revenues from 2010 to 2011 and forecast of these major segments from 2012 to 2018. Similar detailed analysis is conducted for cardiovascular implants, intraocular implants and breast implants. The overall analysis of the competitiveness of the U.S. market for the above products is included in the report. These factors along with the strategic recommendations would be helpful in taking fair corporate decisions related to the products' market.

In addition, this report covers the major players currently active in the U.S. implantable devices market. The company profiling done in this report will be of vital assistance in mapping the competition in the market. The profiles cover the financial and strategic overview of the key players and their SWOT analysis and recent developments.

Secondary research has been employed for deriving the market numbers for each segment of the research report and have been further validated with C-level executives of major companies operating in the implantable medical devices market through means of primary research to finally come up with definite results. This research is specially designed to estimate and analyze the performance of prime implantation devices in the U.S. market. The research provides in-depth analysis of the devices' market revenue and trend analysis. The report also covers all the major product types and procedures of the implantable medical devices market and provides detailed analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the U.S. market as below:

U.S. implantable medical devices market, product segmentation

Orthopedic implants
Reconstructive joint replacement
Spinal implants

Cardiovascular implants
Dental implants
Intraocular lens
Breast implants
Other implants

U.S. implantable medical devices market, by procedures

Orthopedic procedures
Cardiovascular procedures
Other procedures


The in-depth research and high level analysis will allow implantable medical device providers, lawmakers, equipment manufacturers, medical companies and research and development agencies to make informed decisions about implantable device product manufacturing, designing, marketing, growth strategies and gain competitive advantage.

Table of Contents

Chapter 1 Preface
1.1 Research Scope And Description
1.2 Research Methodology

Chapter 2 Executive Summary

Chapter 3 U.S. Implantable Medical Devices Market Analysis
3.1 Introduction
3.1.1 Market Environment
3.1.2 Policy Issues
3.1.3 U.S. Key Indicators For Implantable Medical Devices
3.2 Market Drivers
3.2.1 High Incidence Of Chronic Degenerative Diseases
3.2.2 Increase In Aging Population
3.2.3 Rise In Purchasing Parity And Increase In Healthcare Expenditure
3.3 Market Restraints
3.3.1 High Price Of Implantable Devices
3.4 Market Opportunities
3.4.1 Technical Innovation
3.5 Porter's Five Forces Analysis
3.5.1 Bargaining Power Of Buyers
3.5.2 Bargaining Power Of Suppliers
3.5.3 Threat Of Substitutes
3.5.4 Threat Of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis
3.6.1 U.S. Implantable Medical Devices Market, Market Attractiveness Analysis, 2011

Chapter 4 U.S. Implantable Medical Devices Market, Product Segmentation
4.1 Overview
4.1.1 Current Scenario
4.1.1.1 U.S. Implantable Medical Devices Market – Trends and Forecast, 2010 - 2018 (USD Million)
4.1.2 U.S. Orthopedic Implants Market
4.1.2.1 Current scenario
4.1.2.2 Reconstructive Joint Replacements
4.1.2.2.1 U.S. Reconstructive Joint Replacement Market – Trends and Forecast, 2010 – 2018 (USD Million)
4.1.2.3 Spinal Implants
4.1.2.3.1 U.S. Spinal Implants Market – Trends and Forecast, 2010 – 2018 (USD Million)
4.1.2.4 Orthobiologics
4.1.2.5 Trauma fixation implants
4.1.2.6 Other Implants
4.1.3 Cardiovascular Implants
4.1.3.1 U.S. Cardiovascular Implants Market – Trends and Forecast, 2010 – 2018 (USD Million)
4.1.3.2 Pacing Devices
4.1.3.3 Structural Cardiac Devices
4.1.3.4 Cardiac Stents
4.1.4 Dental Implants
4.1.4.1 U.S. Dental Implants Market – Trends and Forecast, 2010 – 2018 (USD Million)
4.1.5 Intraocular Lens (Iols)
4.1.5.1 U.S. Intraocular Lens Market – Trends and Forecast, 2010 – 2018 (USD Million)
4.1.6 Breast Implants
4.1.6.1 U.S. Breast Implants Market – Trends and Forecast, 2010 – 2018 (USD Million)
4.1.7 Other Implants
4.1.7.1 U.S. Other Implantable Medical Devices Market, Trends and Forecast, 2010 – 2018 (USD Million)

Chapter 5 U.S. Implantable Medical Devices Market, By Procedures
5.1 Overview
5.2 U.S. Orthopedic Implant Procedures – Trends And Forecast, 2010 – 2018
5.2.1 U.S. Orthopedic Implant Procedures Market, 2010 – 2018
5.2.2 Knee Replacements
5.2.3 Spinal Fusion And Fixation
5.2.3.1 U.S. Spinal Fusion and Fixation Procedures Market, Trend and Forecast, 2010 - 2018
5.2.4 Fracture Repair Procedures
5.3 U.S. Cardiovascular Implant Procedures – Trends And Forecast, 2010 – 2018
5.3.1 U.S. Cardiovascular Implant Procedures Market, 2010 – 2018
5.3.2 Stenting Procedures
5.3.2.1 U.S. Stenting Procedures Market, Trend and Forecast, 2010 – 2018
5.3.3 Defibrillator Implantation
5.3.3.1 U.S. Defibrillator Implantation Procedures Market, Trend And Forecast, 2010 – 2018
5.4 U.S. Other Implant Procedures – Trends And Forecast, 2010 – 2018
5.4.1 Intraocular Lens Implant Procedures
5.4.2 Breast Augmentation
5.4.2.1 U.S. Breast Augmentation Procedures Market, Trend and Forecast, 2010 – 2018

Chapter 6 Competitive Landscape And Recommendations
6.1 Market Share Analysis Of Key Players, 2011
6.1 Market Strategy For Success
6.2 Barriers To Be Considered

Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Swot Analysis
7.1.4 Product Portfolio
7.1.1 Strategic Developments
7.1.1.1 Business Diversification
7.1.1.2 R&D Initiatives
7.1.1.3 Investing In Emerging Markets
7.1.2 Recent Developments
7.2 Alcon Laboratories
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Swot Analysis
7.2.4 Product Portfolio
7.2.5 Recent Developments
7.3 Biomet Incorporated
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Swot Analysis
7.3.4 Strategic Developments
7.3.4.1 Mergers, Acquisitions And Takeovers
7.3.5 Recent Developments
7.4 Bausch And Lomb Incorporated
7.4.1 Company Overview
7.4.2 Swot Analysis
7.4.3 Strategic Developments
7.4.3.1 Mergers, Acquisitions And Takeovers
7.4.3.2 New Product Launches
7.4.4 Recent Developments
7.5 Boston Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Swot Analysis
7.5.4 Strategic Developments
7.5.4.1 Mergers, Acquisitions And Takeovers
7.5.4.2 New Product Approvals
7.5.5 Recent Developments
7.6 Johnson And Johnson
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Swot Analysis
7.6.4 Strategic Developments
7.6.4.1 Mergers, Acquisitions And Takeovers
7.6.4.2 New Product Approvals And Launch
7.6.5 Recent Developments
7.7 Medtronic Incorporated
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Swot Analysis
7.7.4 Product Portfolio
7.7.5 Strategic Developments
7.7.6 Recent Developments
7.8 St. Jude Medical Incorporated
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Swot Analysis
7.8.4 Strategic Developments
7.8.4.1 Significant R&D Investments For New Product Development
7.8.4.2 Mergers And Acquisitions
7.8.5 Recent Developments
7.9 Smith And Nephew Plc
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Swot Analysis
7.9.4 Strategic Developments
7.9.4.1 Mergers, Acquisitions And Takeovers
7.9.5 Recent Developments
7.10 Stryker Corporation
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Swot Analysis
7.10.4 Strategic Developments
7.10.4.1 Mergers, Acquisitions And Takeovers
7.10.5 Recent Developments
7.11 Synthes Incorporated
7.11.1 Company Overview
7.11.2 Financial Overview
7.11.3 Swot Analysis
7.11.4 Strategic Developments
7.11.5 Recent Developments
7.12 Zimmer Holdings Incorporated
7.12.1 Company Overview
7.12.2 Financial Overview
7.12.3 Swot Analysis
7.12.4 Strategic Developments
7.12.5 Recent Developments

List of Figures

fig. 1 U.S. Implantable Medical Devices Market, By Types Of Implants, 2011 (Usd Million)
Fig. 2 Porter's Five Forces Analysis For The U.S. Implantable Medical Devices Market
Fig. 3 U.S. Implantable Medical Devices Market Attractiveness Analysis, 2011
Fig. 4 U.S. Implantable Medical Devices Market, 2010 – 2018 (Usd Million)
Fig. 5 U.S. Orthopedic Implants Market, 2010 – 2018 (Usd Million)
Fig. 6 U.S. Reconstructive Joint Replacement Market, 2010 – 2018 (Usd Million)
Fig. 7 U.S. Spinal Implants Market, 2010 – 2018 (Usd Million)
Fig. 8 U.S. Cardiovascular Implants Market, 2010 – 2018 (Usd Million)
Fig. 9 U.S. Dental Implants Market, 2010 – 2018 (Usd Million)
Fig. 10 U.S. Intraocular Lens Market, 2010 – 2018 (Usd Million)
Fig. 11 U.S. Breast Implants Market, 2010 – 2018 (Usd Million)
Fig. 12 U.S. Other Implantable Medical Devices Market, 2010 – 2018 (Usd Million)
Fig. 13 U.S. Orthopedic Implants Procedures Market, 2010 – 2018 (Million)
Fig. 14 U.S. Spinal Fusion And Fixation Procedures Market, 2010 – 2018 (Million)
Fig. 15 U.S. Cardiovascular Implant Procedures Market, 2010 – 2018 (Million)
Fig. 16 U.S. Stenting Procedures Market, 2010 – 2018 (Million)
Fig. 17 U.S. Defibrillator Implantation Procedures Market, 2010 – 2018 (Million)
Fig. 18 U.S. Breast Augmentation Procedures Market, 2010 – 2018 (Million)
Fig. 19 Abbott Laboratories: Net Sales, 2009 – 2011 (Usd Million)
Fig. 20 Alcon Laboratories: Net Sales, 2009 – 2011 (Usd Million)
Fig. 21 Biomet Incorporated: Net Sales, 2009 – 2011 (Usd Million)
Fig. 22 Boston Scientific: Net Sales, 2009 – 2011 (Usd Million)
Fig. 23 Johnson & Johnson: Net Sales, 2009 – 2011 (Usd Million)
Fig. 24 Medtronic Inc: Net Sales, 2009 – 2011 (Usd Million)
Fig. 25 St Jude Medical Inc.: Net Sales, 2009 – 2011 (Usd Million)
Fig. 26 Smith And Nephew Plc: Net Sales, 2009 – 2011 (Usd Million)
Fig. 27 Stryker Corporation: Net Sales, 2009 – 2011 (Usd Million)
Fig. 28 Synthes Corporation: Net Sales, 2009 – 2011 (Usd Million)
Fig. 29 Zimmer Holdings Inc.: Net Sales, 2009 – 2011 (Usd Million)

List of Tables

Table 1 The U.S. Implantable Medical Devices Market: Snapshot

To order this report:
Orthopedic Industry:
Implantable Medical Devices Market (Reconstructive Joint Replacement, Spinal Implants, Cardiovascular Implants, Dental Implants, Intraocular Lens And Breast Implants) - U.S. Industry Analysis, Size, Share, Trends, Growth And Forecast, 2012 - 2018

Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

IoT & Smart Cities Stories
The deluge of IoT sensor data collected from connected devices and the powerful AI required to make that data actionable are giving rise to a hybrid ecosystem in which cloud, on-prem and edge processes become interweaved. Attendees will learn how emerging composable infrastructure solutions deliver the adaptive architecture needed to manage this new data reality. Machine learning algorithms can better anticipate data storms and automate resources to support surges, including fully scalable GPU-c...
Machine learning has taken residence at our cities' cores and now we can finally have "smart cities." Cities are a collection of buildings made to provide the structure and safety necessary for people to function, create and survive. Buildings are a pool of ever-changing performance data from large automated systems such as heating and cooling to the people that live and work within them. Through machine learning, buildings can optimize performance, reduce costs, and improve occupant comfort by ...
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
René Bostic is the Technical VP of the IBM Cloud Unit in North America. Enjoying her career with IBM during the modern millennial technological era, she is an expert in cloud computing, DevOps and emerging cloud technologies such as Blockchain. Her strengths and core competencies include a proven record of accomplishments in consensus building at all levels to assess, plan, and implement enterprise and cloud computing solutions. René is a member of the Society of Women Engineers (SWE) and a m...
Poor data quality and analytics drive down business value. In fact, Gartner estimated that the average financial impact of poor data quality on organizations is $9.7 million per year. But bad data is much more than a cost center. By eroding trust in information, analytics and the business decisions based on these, it is a serious impediment to digital transformation.
Digital Transformation: Preparing Cloud & IoT Security for the Age of Artificial Intelligence. As automation and artificial intelligence (AI) power solution development and delivery, many businesses need to build backend cloud capabilities. Well-poised organizations, marketing smart devices with AI and BlockChain capabilities prepare to refine compliance and regulatory capabilities in 2018. Volumes of health, financial, technical and privacy data, along with tightening compliance requirements by...
Predicting the future has never been more challenging - not because of the lack of data but because of the flood of ungoverned and risk laden information. Microsoft states that 2.5 exabytes of data are created every day. Expectations and reliance on data are being pushed to the limits, as demands around hybrid options continue to grow.
Digital Transformation and Disruption, Amazon Style - What You Can Learn. Chris Kocher is a co-founder of Grey Heron, a management and strategic marketing consulting firm. He has 25+ years in both strategic and hands-on operating experience helping executives and investors build revenues and shareholder value. He has consulted with over 130 companies on innovating with new business models, product strategies and monetization. Chris has held management positions at HP and Symantec in addition to ...
Enterprises have taken advantage of IoT to achieve important revenue and cost advantages. What is less apparent is how incumbent enterprises operating at scale have, following success with IoT, built analytic, operations management and software development capabilities - ranging from autonomous vehicles to manageable robotics installations. They have embraced these capabilities as if they were Silicon Valley startups.
As IoT continues to increase momentum, so does the associated risk. Secure Device Lifecycle Management (DLM) is ranked as one of the most important technology areas of IoT. Driving this trend is the realization that secure support for IoT devices provides companies the ability to deliver high-quality, reliable, secure offerings faster, create new revenue streams, and reduce support costs, all while building a competitive advantage in their markets. In this session, we will use customer use cases...